Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE007758 |
YEM_ID: | YEM-743 |
ID: | TCMBANKHE007758/YEM-743 |
植物拉丁名: |
|
功能与主治: | To nourish yin, promote the production of body fluid, and relieve dryness syndromes./Lung stomach yin damage, dry cough, dry throat, diabetes mellitus due to internal heat. |
药用植物名: | 玉竹 |
药名: | 玉竹 |
来源: | 云南民族药物志：第四卷 |
药用部位: | rhizome |
使用民族: | 哈尼族/傈僳族/瑶族/彝族/壮族 |
药味: | Mild; Sweet |
经络: | Lung; Stomach |
临床特征: | 1. Its decoction exerts a cardiotonic effect in frogs.2. Its decoction inhibits the growth of Staphylococcus aureus, Proteus and Bacillus coli in a concentration of 1:320, 1:160, 1:20 respectively in vitro. |
治疗类型: | 补阴药 |
TCM_ID_id: | 8088 |
SymMap_id: | 468 |
TCMSP_id: | 816 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000100 | lauric acid | NCGC00090919-01; CHEBI:30805; n-Dodecanoic acid; Hydrofol acid 1255; Wecoline 1295; Neo-Fat 12-43; 8045-27-0; WLN: QV11; AI3-00112; AIDS-049202; 61609_FLUKA; Dodecylcarboxylate; DAO; EINECS 205-582-1; L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUROYL; CCRIS 669; W261408_ALDRICH; lauric acid ; 8000-62-2; DODECANOIC ACID (LAURIC ACID); C-1297; 7632-48-6; ST023796; NSC5026; Laurinsaeure; C02679; [2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM; Dodecoic acid; Laurostearic acid; NCGC00090919-02; 4-02-00-01082 (Beilstein Handbook Reference); lauricacid; Ninol AA62 extra; InChI=1/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14; Lauric acid (natural); Aliphat No. 4; NSC-5026; Coconut oil fatty acids; Lauric acid, pure; 203714-07-2; NCIOpen2_009480; CH3-[CH2]10-COOH; Dodecylic acid; Neo-Fat 12; AIDS049202; C12 fatty acid; HSDB 6814; Dodecanoic acid; L556_ALDRICH; Lauric acid; LAP; Univol U-314; FEMA No. 2614; 1-Undecanecarboxylic acid; Vulvic acid; 143-07-7; BRN 1099477; Duodecylic acid; LAU; W261416_ALDRICH; LMFA01010012; L4250_SIGMA; Hydrofol acid 1295 | C12H24O2 | 200.32 | CCCCCCCCCCCC(=O)O |
| TCMBANKIN000307 | Convallasaponin A_qt | C32H52O9 | 580.75 | ||
| TCMBANKIN000639 | Convallasaponin A | convallasaponin a | C32H52O9 | 580.75 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(CC(C6)OC7C(C(C(CO7)O)O)O)O)C)O)C)C)OC1 |
| TCMBANKIN002600 | liriodendrin_qt | 7'-epi-(-)-syringaresinol | C34H46O18 | 742.72 | |
| TCMBANKIN002963 | (25R)-tupichigenin-5-O-β-D-glucopyranoside | ||||
| TCMBANKIN004097 | STOCK1N-66370 | 414.69 | |||
| TCMBANKIN004938 | 25(R)spirost-5-en-3beta-ol-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylylpyranylosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galactopyranose_qt | 3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S and R)-spirost-5-en-3beta,14alpho-diol_qt | 430.69 | ||
| TCMBANKIN006029 | polygosides E_qt | polygosides C_qt; polygosides D_qt | 412.67 | ||
| TCMBANKIN006338 | 3β,14-dihydroxy-13-methoxy-8,11,13-podo-carpatrien-7-one | C18H24O4 | CC1(C(CCC2(C1CC(=O)C3=C2C=CC(=C3O)OC)C)O)C | ||
| TCMBANKIN007092 | glucuronic acid | ZINC3869801; CHEBI:28860; glucuronicacid; C08350; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxytetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxy-2-tetrahydropyrancarboxylic acid; BDP; beta-D-Glucuronic acid; (2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid; GCU; BETA-D-GALACTOPYRANURONIC ACID; beta-L-Altropyranuronic acid; beta-D-Glucopyranuronic acid; SCHEMBL15596882; BIG1006 | C6H10O7 | 194.14 | C1(C(C(OC(C1O)O)C(=O)O)O)O |
| TCMBANKIN007258 | Yamogenin | WQLVFSAGQJTQCK-CAKNJAFZSA-N; (25S)-spirost-5-en-3beta-ol; NSC 226132; LMST01080045; AC1L9BVW; AC-8895; S00020; (2R,5'S)-5'-tetramethylspiro[[?]-2,2'-tetrahydropyran]ol; Jamogenin; Neodiosgenin; AKOS025402417; CHEBI:10086; Spirost-5-en-3-ol, (3beta,25S)-; SCHEMBL6040875; CHEMBL400807; C08918; yamogenin; ZINC8234229; 512-06-1; 25-epi-Diosgenin | C27H42O3 | 414.62 | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
| TCMBANKIN008658 | 4',5,7-trihydroxy-6-methyl-homoisoflavanone | 300.33 | |||
| TCMBANKIN008748 | 7'-n-butanol-N-trans-feruloyloctopamine | 385.5 | |||
| TCMBANKIN011812 | ()-alpha-Funebrene | 47991_FLUKA; ()-1,7-Diepi-alpha-cedrene | C15H24 | 204.35 | |
| TCMBANKIN014806 | polygosides B_qt | 430.69 | |||
| TCMBANKIN014884 | ophipogonin D_qt | prosapogenin A of dioscin_qt; lililancifoloside A_qt; Diosgenin-3-O-beta-D-glucopyranoside_qt; 25(R,S)spirost-5-en-3beta-ol-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylylpyranylosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galactopyranose_qt | 414.69 | ||
| TCMBANKIN015058 | 4',5,7-trihydroxy-6-methyl-8-methoxy-homoisoflavanone | 330.36 | |||
| TCMBANKIN015219 | polygosides A_qt | 3beta,14alpha-dihydroxy-(25S)-sipirost-5-ene; (3beta,14alpha)-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl(1-4)-beta-d-galacopyranosyl-14-hydroxy-(25S)-spirost-5-ene_qt | 430.69 | ||
| TCMBANKIN015280 | polyfuroside_qt | C57H94O29 | 1243.34 | ||
| TCMBANKIN018495 | 4-[(1R,3aS,4R,6aS)-4-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxyphenol | 4-[(1R,3aS,4R,6aS)-4-(4-hydroxy-3,5-dimethoxy-phenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-2,6-dimethoxy-phenol | C22H26O8 | 418.44 | |
| TCMBANKIN020238 | 4',5,7-trihydroxy-6,8-dimethyl-homoisoflavanone | 314.36 | |||
| TCMBANKIN021774 | 3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S)-spirost-5(6)-en-3beta-ol_qt | 414.69 | |||
| TCMBANKIN023810 | 7-TETRADECENE | 10374-74-0; trans-7-Tetradecene; Tetradec-7-ene; 41446-63-3; 7-Tetradecene,c&t; SBB008954; 7-Tetradecene, (E)-; (E)-tetradec-7-ene; (7E)-7-Tetradecene; 227560_ALDRICH; EINECS 233-815-7 | C14H28 | 196.37 | CCCCCCC=CCCCCCC |
| TCMBANKIN024999 | des-o-methycarrine | ||||
| TCMBANKIN025134 | 25(R,S)spirost-5-ene-3beta,14alpha-diol-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylylpyranylosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galactopyranose | 1063.33 | |||
| TCMBANKIN025303 | convallarin | ||||
| TCMBANKIN025500 | Azetidinecarboxylic acid | Acide L-azetidine-2-carboxylic [French]; (2S)-2-azetidinecarboxylic acid; Azetidyl-2-carboxylic acid; L-Azetidine-2-carboxylic acid; (L)-AZETIDINE-2-CARBOXYLIC ACID; CHEBI:6198; A0760_SIGMA; (S)-Azetidine-2-carboxylic acid; L-Azetidine 2-carboxylic acid; EU-0100023; 11542_FLUKA; 2-Azetidinecarboxylic acid, (S)- (9CI); HSDB 3465; EINECS 218-362-5; (S)-(-)-Azetidine-2-carboxylic acid; Azetidine-2-carboxylic acid, L-; 2-Azetidinecarboxylic acid, L-; Lopac0_000023; 2133-34-8; C08267; 2-Azetidinecarboxylic acid, (S)-; (S)-2-Azetidinecarboxylic acid; SBB004365; (2S)-azetidine-2-carboxylic acid | C4H7NO2 | 101.1 | C1CNC1C(=O)O |
| TCMBANKIN026719 | polygosides B | 917.17 | |||
| TCMBANKIN026991 | noricarliin | CC(C)(CCC1=C(C=C(C2=C1OC(=C(C2=O)O)C3=CC=C(C=C3)O)O)O)O | |||
| TCMBANKIN027536 | convallamarin | 1391-12-4 | C57H94O27 | 1211.3 g/mol | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3CC(CC4C3(C5CCC6C(C5CC4)CC7C6(C(C(O7)(CCC(=C)COC8C(C(C(C(O8)CO)O)O)O)O)C)C)C)OC9C(C(C(C(O9)C)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)O)O)O |
| TCMBANKIN027988 | (3beta,14alpha)-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galacopyranosyl-yamogenin | 1033.3 | |||
| TCMBANKIN028598 | polygosides A | 917.17 | |||
| TCMBANKIN028690 | 25(R,S)spirost-5-ene-3beta,14alpha-diol-3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-glucopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-beta-d-galactopyranose | 1079.33 | |||
| TCMBANKIN030383 | polygosides D | 1061.31 | |||
| TCMBANKIN030436 | (22S)-sipirost-5-ene-1beta,3beta,16beta,22-tetrol-1-o-alpha-l-rhamnopyranosyl-16-o-beta-d-glucopyranoside | 743.05 | |||
| TCMBANKIN031336 | 2-Methylnonan-3-one | Hexyl isopropyl ketone; EINECS 226-648-6; 5445-31-8; NSC21991; 2-Methyl-3-nonanone; 3-Nonanone, 2-methyl- | C10H20O | 156.27 | CCCCCCC(=O)C(C)C |
| TCMBANKIN033296 | 3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S)-spirost-5(6)-en-3beta-ol | 1033.3 | |||
| TCMBANKIN033882 | (22S)-sipirost-5-ene-1beta,3beta,16beta,22-tetrol-1-o-alpha-l-rhamnopyranosyl-16-o-beta-d-glucopyranoside_qt | 434.73 | |||
| TCMBANKIN034184 | polygosides E | polygosides C | 1193.44 | ||
| TCMBANKIN035983 | 3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S)-spirost-5(6)-en-3beta,14alpho-diol_qt | 430.69 | |||
| TCMBANKIN036035 | beta-anhydroicariine | ||||
| TCMBANKIN036575 | 3-o-beta-d-glucopyranosyl-(1-2)-[beta-d-xylopyranosyl-(1-3)]-beta-d-glucopyranosyl-(1-4)-galactopyranosyl-25(S)-spirost-5(6)-en-3beta,14alpho-diol | 1049.3 | |||
| TCMBANKIN036846 | Icariin | 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromen-4-one; MLS000759413; Spectrum4_001975; ZINC03960893; 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-chromen-4-one; Spectrum2_001695; 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-3-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxy]-4-chromenone; 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromone; Spectrum3_001130; 5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one; 489-32-7; 2-(4'-methoxyl phenyl)-3-rhamnosido-5-hydroxyl-7-glucosido-8-(3'-methyl-2-butylenyl)-4-chromanone; SPBio_001650; SPECTRUM1505257; KBio3_002099; KBioGR_002475; SDCCGMLS-0066754.P001; SMR000466309; BB_NC-0999; 3-((6-Deoxymannopyranosyl)oxy)-7-(glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one; Spectrum5_000933; icariin; BSPBio_002599; 4H-1-Benzopyran-4-one, 3-((6-deoxy-alpha-L-mannopyranosyl)oxy)-7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-; ICA | C33H40O15 | 677 | O1[C@@]([H])(Oc2c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c(OC(c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H])=C(O[C@@]4([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H ])[H])O4)C5=O)c5c(O[H])c2[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])C([H])([H])O[H] |
| TCMBANKIN037988 | Polyfuroside PO8 | ||||
| TCMBANKIN040516 | Wattoside C | ||||
| TCMBANKIN043528 | Polyfuroside PO6 | ||||
| TCMBANKIN044120 | Polyfuroside PO7 | ||||
| TCMBANKIN047386 | 22-hydroxy-25(r,s)-furost-5-en-12-on-3β,22,26-triol 26-o-β-d-glucopyranoside | C33H52O10 | |||
| TCMBANKIN058094 | 5-HMF | 5-(Hydroxymethyl)-2-furancarboxaldehyde; 5-18-01-00130 (Beilstein Handbook Reference); 2-Furancarboxaldehyde, 5-(hydroxymethyl)-; 2-Hydroxymethyl-5-furfural; BRN 0110889; 5-(Hydroxymethyl)-2-furancarbonal; CCRIS 3160; CBiol_000485; 67-47-0; NSC40738; SBB004259; 2-Furaldehyde, 5-(hydroxymethyl)-; 5-(Hydroxymethyl)-2-furaldehyde; 5-(hydroxymethyl)furan-2-carbaldehyde; Hydroxymethylfurfurole; 5-Hydroxymethylfurfural; 5-Hydroxymethylfuraldehyde; C11101; 5-(Hydroxymethyl)furfural; 5-Oxymethylfurfurole; InChI=1/C6H6O3/c7-3-5-1-2-6(4-8)9-5/h1-3,8H,4H; EINECS 200-654-9; W501808_ALDRICH; Hydroxymethylfurfuralaldehyde; 5-(Hydroxymethyl)-2-furfuraldehyde; ICCB3_000133; H40807_ALDRICH; Hydroxymethylfurfural; 5-Hydroxymethyl-2-furancarboxaldehyde; NCGC00091513-01; 55690_FLUKA; 5-Hydroxymethyl furaldehyde; 5-(Hyddroxymethyl)furfurole; 5-Hydroxymethyl-2-furaldehyde; 5-(Hydroxymethyl)-2-furfural; NSC 40738; 76330-16-0; Hydroxymethylfurfuraldehyde; 5-Hydroxymethyl-2-formylfuran; ZINC00900788; 5-Hydroxymethylfuran-2-aldehyde; 5-methylolfurfural; 5-hydroxymethylfuraldehyde; 5-hydroxymethyl furfural; 5-hydroxy methyl furfural; 5-hydroxymethylfurfural; 2-Furancarboxaldehyde,5-(hydroxymethyl); 5-hydroxymethyl furaldehyde; 5-hydroxymethyl-2-furfural; 5-(hydroxymethyl)-2-furfural; 5- hydroxymethylfurfural; 2-Furancarboxaldehyde , 5-(hydroxymethyl) | C6H6O3 | 126.11 g/mol | C1=C(OC(=C1)C=O)CO |
| TCMBANKIN058468 | quercitol | MFCD06797163; (+)-Quercitol; AC1L9B61; 488-73-3; D-chiro-Inositol, 2-deoxy-; 5-Deoxyinositol; SCHEMBL6079050; CHEBI:27371; d-Quercitol; UNII-M8H1D7SDLM; 2-Deoxy-myo-inositol; ZINC4097493; Quercitol; Q0071; M8H1D7SDLM; Viburnitol; DTXSID80197609; (1R,2S,4S,5R)-cyclohexane-1,2,3,4,5-pentol; CHEMBL1950778; 1L-1,3,4/2,5-cyclohexanepentol; (+)-proto-Quercitol; C08258; Acorn sugar; d-quercitol; (+)-quercitol | C6H12O5 | 164.16 g/mol | C1C(C(C(C(C1O)O)O)O)O |
| TCMBANKIN058640 | 2-azetidinecarboxylic acid | VA80038; AKOS004910733; (2S)-(-)-Azetidine-2-carboxylic acid; CHEMBL33592; Azetidinecarboxylic acid; AK-27256; BB 0262160; FT-0634338; NSC72471; CHEBI:38108; BDBM50000108; A-2380; azetidine-2-carboxylic acid, AldrichCPR; ST1010054; azetidin-1-ium-2-carboxylate; Z1318268680; HT782; J-012991; A814215; FT-0600768; EN002094; DL-2-Azetidinecarboxylic acid; EN300-24071; EINECS 219-740-2; MFCD00066660; CTK1A3520; ACT01822; AC-5888; 4CH-013358; Q848; (RS)-AZETIDINE-2-CARBOXYLIC ACID; 20063-89-2; MCULE-1336085891; 517A046; DL-Azetidine-2-carboxylic acid; SC-53260; 4CH-011944; KB-50282; DL-AzeOH; TL80090703; CA-1879; 2-AZETIDINECARBOXYLIC ACID; (R)-azetidine-2-carboxylicacid; 2-Azetidinecarboxylicacid; DB-008923; ACMC-209yxx; AC-23581; (+)-2-AZETIDINECARBOXYLIC ACID; TL8001772; X2014; KS-00000KFF; K-0016; NSC-72471; azetidine-2-carboxylicacid; AZETIDINE-2-CARBOXYLICACID (L-); 7729-30-8 Azetidine-2-carboxylic acid; AC1NRUXC; Azetidine-2-carboxylic acid; AC-23205; azetidine-2-carboxylate; RP00426; S14-2650; (+/-)-2-AZETIDINECARBOXYLIC ACID; IADUEWIQBXOCDZ-UHFFFAOYSA-N; (RS)-2-AZIRIDINECARBOXYLIC ACID; F8887-4126; KB-47479; A9783; TX-012237; MolPort-002-471-062; SY013679; (+-)-2-Azetidinecarboxylic acid; AN-10538; AC1L29PE; AM20090145; I04-1348; ALBB-023626; QC-9589; D,L-AzeOH; I04-0055; GS-4253; BR-27256; CS-M0178; SCHEMBL122166; AC1Q74O1; DL-H-AZE-OH; 2-Azetidinecarboxylic acid, (S)- (9CI); 2517/4/6; DB-067333; 1-Azetidinecarboxylicacid, 2-(aminocarbonyl)-, 1,1-dimethylethyl ester, (2S)-; J-519619; D,L-Azetidine-2-carboxylic Acid; PB12060; AB0002316; ANW-50569;azetidine-2-carboxylic acid | C4H7NO2 | 101.1 | C1CNC1C(=O)O |
| TCMBANKIN059286 | polyfuroside; (25r)-26-o-β-d-glucopyranosyl-22-hydroxy-furost-5(6)-ene-3β,26-diol-3-o-β-d-glucopyra-nosyl(1→2)[β-d-glucopyranosyl(1→3)]-β-d-glucopyranosyl(1→4)-β-d-galactopyranoside | C57H94O29 | 1243.34 | CC(C1=CC=C(C=C1)S(=O)C)NC(=O)N2CC(C(C2)C(F)(F)F)C(=O)O | |
| TCMBANKIN059532 | (1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one | C10H16O | 152.23 g/mol | CC1(C2CCC1(C(=O)C2)C)C | |
| TCMBANKIN060790 | leaf aldehyde | C6H10O | 98.14 g/mol | CCCC=CC=O | |
| TCMBANKIN060816 | Octadiene | C8H14 | 110.2 g/mol | CCCCC=CC=C | |
| TCMBANKIN060840 | Vinyl amyl ketone | C8H14O | 126.2 | CCCCCC(=O)C=C | |
| TCMBANKIN060853 | CHEBI:39932 | C8H16O | 128.21 | CCCCCC(C=C)O | |
| TCMBANKIN060888 | caproaldehyde | C6H12O | 100.16 g/mol | CCCCCC=O | |
| TCMBANKIN060891 | 2-Amyl furan | C9H14O | 138.21 g/mol | CCCCCC1=CC=CO1 | |
| TCMBANKIN060910 | cis-9-hexadecenoic acid | C16H30O2 | 254.41 g/mol | CCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061006 | lauric acid | C12H24O2 | 200.32 | CCCCCCCCCCCC(=O)O | |
| TCMBANKIN061045 | PENTADECYLIC ACID | C15H30O2 | 242.4 g/mol | CCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061197 | n-Hexyl formate | C7H14O2 | 130.18 g/mol | CCCCCCOC=O | |
| TCMBANKIN061574 | feruloyltyramine | n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine | C18H19NO4 | 313.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab